Search

Your search keyword '"Santos, Beatriz"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Santos, Beatriz" Remove constraint Author: "Santos, Beatriz" Journal journal of hepatology Remove constraint Journal: journal of hepatology
23 results on '"Santos, Beatriz"'

Search Results

1. FRI-472-YI Mitochondrial metabolism is disrupted by ciprofloxacin preventing cholangiocarcinoma cell proliferation

2. THU-210 Dysfunctional activation of the DNA damage response is associated with MASLD progression through an E2F2-dependent mechanism

3. FRI-343-YI APAP induced liver damage is prevented by activation of PPARgamma and PPAR-alpha

4. OS-101-YI Remodelling of hepatocyte cholesterol metabolism mediates colorectal liver metastasis

5. TOP-229-YI The E2F2 target glycerophosphodiester phosphodiesterase domain containing 3 is involved in MASLD progression to HCC and related dyslipidemias

6. The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH

7. Microbiota-targeted interventions in the gut-liver axis for chronic liver disease of DUAL etiology

8. Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism

9. E2F2 deficiency protects from acetaminophen-induced hepatotoxicity while E2F1 is required to prevent the devastating effects

10. E2F2-promoted DNA damage in NASH worsens the metabolic scenario

11. The uptake of extracellular lipids promotes cholangiocarcinoma progression

12. miR34a-5p is a target of E2F2 transcription factor in MAFLD-related HCC

13. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis

14. The DNA damage response is involved in the metabolic dysregulation of MAFLD patients via inefficient fatty acid oxidation

15. Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH

16. WED-408 - E2F2-promoted DNA damage in NASH worsens the metabolic scenario

17. WED-404 - The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH

18. SAT-215 - Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism

19. THU-235 - Microbiota-targeted interventions in the gut-liver axis for chronic liver disease of DUAL etiology

20. FRI-395 - E2F2 deficiency protects from acetaminophen-induced hepatotoxicity while E2F1 is required to prevent the devastating effects

21. FRI-294-Mitochondrial GNMT-complex II is recovered by miR-873-5p targeting in NAFLD

22. PS-015-Role of methylation-controlled J-protein, endogenous repressor of the mitochondrial respiratory chain, in cholestatic liver disease

23. PS-008-E2F2 mediated repression of fatty acid B-oxidation is mitigated through CREB1 in progressive non-alcoholic fatty liver disease

Catalog

Books, media, physical & digital resources